Repositori Institucional UIB
Publication
Artículo científico (JournalArticle)
Transfusion-transmitted leishmaniasis: a practical review [preprint]
[eng] Background: In the Balearic Islands, as in other areas in southern Europe, there is a significant proportion of asymptomatic L. infantum infected blood donors. Theoretically, these donors may represent an important challenge for blood transfusion safety. On the other hand, there is scarce evidence of the transfusion transmission leishmaniasis (TTL) in the literature. Study design and methods: Although most Leishmania infections are asymptomatic, longitudinal follow-up has shown that some individuals eventually develop clinical leishmaniasis. To investigate Leishmania infection evolution in asymptomatic carriers, a
follow-up study was performed in 20 asymptomatic blood donors from the Balearic Islands between 2008 and 2011. Anti-Leishmania antibodies and blood Leishmania DNA by qPCR was determined at different intervals. Additionally, the prevalence of L. infantum infection was investigated in a group of multiply transfused patients to ascertain the TTL risk in our region, taking into account our regular blood component
production practices such as leukodepletion and pathogen reduction technology (PRT). Results: All 20 donors remained asymptomatic over the study period. Most donors had either persistently or intermittently repeated positive qPCR results. Parasitemia levels were remarkably low in asymptomatic donors, ranged from 0.01 parasites/mL to 1 parasite/mL. No transfused patient in the study was infected. Conclusion: Leishmania infantum infected donors can remain asymptomatic for at least three years. In our region, no cases of TTL have been detected despite the active search in multiply transfusion patients. This could be associated with the implementation of methods proven to be effective against TTL, such as leukodepletion and PRT.